10/28
03:08 pm
cslly
Transforming pharmaceutical R&D: the impact of digital technologies on drug discovery and development [Yahoo! Finance]
Low
Report
Transforming pharmaceutical R&D: the impact of digital technologies on drug discovery and development [Yahoo! Finance]
10/18
08:30 am
cslly
New Data Presented at IDWeek 2024 Show Adjuvanted and High-Dose Influenza Vaccines are Comparable in Protecting Adults 65 Years of Age and Older Against Seasonal Influenza
Low
Report
New Data Presented at IDWeek 2024 Show Adjuvanted and High-Dose Influenza Vaccines are Comparable in Protecting Adults 65 Years of Age and Older Against Seasonal Influenza
10/16
09:00 am
cslly
CSL Seqirus Presents Data at IDWeek 2024 Highlighting the Urgent Need to Increase Influenza Vaccination Rates and the Benefits of Cell-Based Influenza Vaccines
Low
Report
CSL Seqirus Presents Data at IDWeek 2024 Highlighting the Urgent Need to Increase Influenza Vaccination Rates and the Benefits of Cell-Based Influenza Vaccines
10/7
06:00 pm
cslly
Pharmanovia Acquires Exclusive Rights to Treatment for Parkinson’s Disease
Low
Report
Pharmanovia Acquires Exclusive Rights to Treatment for Parkinson’s Disease
10/4
12:30 pm
cslly
CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Sixth BARDA Award in Response to Avian Influenza
Low
Report
CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Sixth BARDA Award in Response to Avian Influenza
10/1
11:00 am
cslly
CSL Seqirus Presents Real-World Evidence at OPTIONS XII Conference Highlighting Effectiveness of Influenza Vaccinations
Low
Report
CSL Seqirus Presents Real-World Evidence at OPTIONS XII Conference Highlighting Effectiveness of Influenza Vaccinations
9/25
04:34 pm
cslly
CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Fifth BARDA Award in Response to Avian Influenza Outbreak [Yahoo! Finance]
Low
Report
CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Fifth BARDA Award in Response to Avian Influenza Outbreak [Yahoo! Finance]
9/25
04:30 pm
cslly
CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Fifth BARDA Award in Response to Avian Influenza Outbreak
Low
Report
CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Fifth BARDA Award in Response to Avian Influenza Outbreak
9/24
03:30 am
cslly
Veltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemia
Low
Report
Veltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemia
9/24
03:30 am
cslly
Veltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemia
Low
Report
Veltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemia
9/24
03:30 am
cslly
Veltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemia
Low
Report
Veltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemia
9/17
11:30 am
cslly
Mark Cuban Foundation and CSL Bring Free AI Bootcamp to Philadelphia Teens
Low
Report
Mark Cuban Foundation and CSL Bring Free AI Bootcamp to Philadelphia Teens
9/17
09:05 am
cslly
CSL Joins Accumulus Synergy to Drive Industry Change
Low
Report
CSL Joins Accumulus Synergy to Drive Industry Change